Innospec Inc.
NASDAQ:IOSPChemicals - Specialty
+$0.08 today
- Market cap
- $1.94B
- Beta
- 0.91
- P/E (TTM)
- 18.0
- EPS (TTM)
- $4.61
- Dividend yield
- 2.15%
Volume 0.23M
Average 0.24M
IOSP Total Liabilities
Everything the company owes to creditors and other parties.
Innospec Inc.NASDAQ: IOSP
Total Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total liabilities broadly unchanged from a year ago
Total liabilities stood at $495.2M at the end of Q2 FY2026, down 1.9% from a year earlier and up 5.9% from the prior quarter. Over 3 fiscal years it compounded at -3.9% a year.
Context
- Total liabilities amounted to 26.8% of total assets at the end of Q2 FY2026, down 1.1 pp from a year earlier.
- Total liabilities increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps falling in the next quarterly balance sheet after a -1.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 499.5M USD
- Year-over-year change
- -3.7%
- 4-year CAGR
- -1.8%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 499.5M | -3.7% |
| FY2024 | 2024-12-31 | 518.6M | -7.0% |
| FY2023 | 2023-12-31 | 557.8M | -1.0% |
| FY2022 | 2022-12-31 | 563.3M | +4.7% |
| FY2021 | 2021-12-31 | 537.9M | — |
Total Liabilities vs competitors
How IOSP compares with its peers on the latest reported figures
- IOSP's Jun 2026 total liabilities of $495.2M is the 8th highest of the 10 companies compared; the peer median is $2.24B.
- Its year-over-year change of -1.9% is the 8th highest of 10, against a peer median of +1.6%.
- Total liabilities amounts to 26.8% of total assets for IOSP, versus a peer median of 56.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $9.25B | -0.7% | -2.2% | 60.0% | |
| Sep 2026 | $3.6B | +13.0% | +1.6% | 120.1% | |
| Aug 2026 | $3.26B | +1.6% | +3.7% | 60.1% | |
| Jun 2026 | $2.71B | -0.9% | -3.3% | 59.2% | |
| Jun 2026 | $2.24B | +4.0% | -5.4% | 56.4% | |
| Jun 2026 | $1.78B | +12.6% | +1.4% | 49.2% | |
| Sep 2026 | $1.5B | +3.3% | -2.7% | 51.4% | |
| Jun 2026 | $495.2M | -1.9% | -3.9% | 26.8% | |
| Sep 2026 | $335.61M | -29.7% | +22.8% | 33.2% | |
| Mar 2026 | $37.07M | -5.6% | -19.9% | 20.7% | |
| Peer median (excluding IOSP) | $2.24B | +1.6% | -2.2% | 56.4% | |
Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 141.8M | 147.1M | 203.7M | 289.2M | 292.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 284.5M | 334.6M | 359.8M | 341.7M | 342.3M |
| Inventory | 277.6M | 373.1M | 300.1M | 301M | 329.3M |
| Other Current Assets | 400K | 400K | 600K | 600K | 7.3M |
| Total Current Assets | 728.1M | 872.6M | 885.7M | 956.6M | 1B |
| Property, Plant & Equipment (Net) | 249.8M | 266.2M | 313.4M | 314.5M | 338.8M |
| Goodwill | 364.3M | 358.8M | 399.3M | 382.5M | 399M |
| Intangible Assets | 57.5M | 45M | 57.3M | 65.4M | 67.7M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 6.4M | 5.9M | 10.4M | 9.4M | 13.6M |
| Other Non-current Assets | 164.8M | 55.2M | 41.3M | 6.3M | 8.7M |
| Total Non-current Assets | 842.8M | 731.1M | 821.7M | 778.1M | 827.8M |
| Total Assets | 1.57B | 1.6B | 1.71B | 1.73B | 1.83B |
| Account Payables | 148.7M | 165.3M | 163.6M | 163.8M | 174.7M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 3.7M | 18.4M | 2.6M | 3.1M | 13.1M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.2M | 5.3M | 5.8M | 5M | 11.9M |
| Total Current Liabilities | 336.6M | 405.8M | 371.5M | 371.4M | 360.1M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 60.8M | 26.2M | 33.5M | 23.5M | 19.1M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 117.4M | 99.9M | 121.2M | 92.7M | 83.5M |
| Total Non-current Liabilities | 201.3M | 157.5M | 186.3M | 147.2M | 139.4M |
| Total Liabilities | 537.9M | 563.3M | 557.8M | 518.6M | 499.5M |
| Common Stock | 300K | 300K | 300K | 300K | 300K |
| Retained Earnings | 822.9M | 924.2M | 1.03B | 1.03B | 1.1B |
| Accumulated OCI | (46.9M) | (145.2M) | (148.1M) | (91M) | (34.7M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 600K | 2.4M | 2.5M | 4.9M | 6.8M |
| Total Equity | 1.03B | 1.04B | 1.15B | 1.22B | 1.33B |
| Total Debt | 35.6M | 45.3M | 45.2M | 44.9M | 52.7M |
| Net Debt | (106.2M) | (101.8M) | (158.5M) | (244.3M) | (239.8M) |
Innospec Inc.
NASDAQ:IOSP
Intrinsic Alpha fair value
Locked
Current Price
$78.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.